Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

FIONA MAGILL SHAW

Allopathic & Osteopathic Physicians Dermatology

NPI
1710341870
CMS profile
11391975
Location
FAIRFAX, VA

General Payments · PY2022–2024

$1,991.25

  • Reported across 76 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$960.07

37 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $960.07 37

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Galderma Laboratories, L.P. $201.68 3
ABBVIE INC. $154.97 12
GENZYME CORPORATION $130.00 1
Amgen Inc. $117.43 4
Regeneron Healthcare Solutions, Inc. $68.16 3
Lilly USA, LLC $65.63 3
Incyte Corporation $46.50 2
Dermavant Sciences, Inc. $46.38 2
Janssen Biotech, Inc. $39.72 2
LEO Pharma Inc. $29.33 1
Organon LLC $17.44 1
Almirall LLC $15.70 1
Arcutis Biotherapeutics, Inc. $13.99 1
PFIZER INC. $13.14 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2022 $39.21 2
PY2023 $991.97 37
PY2024 $960.07 37

Payment records · PY2024 (37)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $18.81 01/30/2024 Food and Beverage Undisputed 01/23/2026 1106077949 CMS
ABBVIE INC. $11.48 02/13/2024 Food and Beverage Undisputed 01/23/2026 1106077951 CMS
ABBVIE INC. $33.33 02/13/2024 Food and Beverage Undisputed 01/23/2026 1106077953 CMS
ABBVIE INC. $0.64 02/27/2024 Food and Beverage Undisputed 01/23/2026 1106077955 CMS
ABBVIE INC. $5.47 02/28/2024 Food and Beverage Undisputed 01/23/2026 1106077957 CMS
ABBVIE INC. $5.39 02/28/2024 Food and Beverage Undisputed 01/23/2026 1106077959 CMS
ABBVIE INC. $1.70 02/28/2024 Food and Beverage Undisputed 01/23/2026 1106077961 CMS
ABBVIE INC. $22.14 03/19/2024 Food and Beverage Undisputed 01/23/2026 1106077963 CMS
ABBVIE INC. $14.42 05/15/2024 Food and Beverage Undisputed 01/23/2026 1106077965 CMS
ABBVIE INC. $17.66 06/24/2024 Food and Beverage Undisputed 01/23/2026 1106077967 CMS
ABBVIE INC. $9.72 09/18/2024 Food and Beverage Undisputed 01/23/2026 1106077969 CMS
ABBVIE INC. $14.21 12/04/2024 Food and Beverage Undisputed 01/23/2026 1106077971 CMS
Almirall LLC $15.70 03/18/2024 Food and Beverage Undisputed 01/23/2026 1120642971 CMS
Amgen Inc. $31.79 03/11/2024 Food and Beverage Undisputed 01/23/2026 1117380966 CMS
Amgen Inc. $24.99 06/17/2024 Food and Beverage Undisputed 01/23/2026 1117380968 CMS
Amgen Inc. $31.98 10/07/2024 Food and Beverage Undisputed 01/23/2026 1117380970 CMS
Amgen Inc. $28.67 12/16/2024 Food and Beverage Undisputed 01/23/2026 1117380972 CMS
Arcutis Biotherapeutics, Inc. $13.99 02/27/2024 Food and Beverage Undisputed 01/23/2026 1121047153 CMS
Dermavant Sciences, Inc. $26.76 06/04/2024 Food and Beverage Undisputed 01/23/2026 1127932387 CMS
Dermavant Sciences, Inc. $19.62 12/02/2024 Food and Beverage Undisputed 01/23/2026 1127932391 CMS
Galderma Laboratories, L.P. $54.88 05/09/2024 Food and Beverage Undisputed 01/23/2026 1145327796 CMS
Galderma Laboratories, L.P. $127.87 06/27/2024 Food and Beverage Undisputed 01/23/2026 1145327798 CMS
Galderma Laboratories, L.P. $18.93 08/28/2024 Food and Beverage Undisputed 01/23/2026 1145327800 CMS
GENZYME CORPORATION $130.00 11/04/2024 Food and Beverage Undisputed 01/23/2026 1139930977 CMS
Incyte Corporation $24.97 05/07/2024 Food and Beverage Undisputed 01/23/2026 1141182976 CMS
Incyte Corporation $21.53 09/16/2024 Food and Beverage Undisputed 01/23/2026 1141221108 CMS
Janssen Biotech, Inc. $18.07 01/23/2024 Food and Beverage Undisputed 01/23/2026 1078796871 CMS
Janssen Biotech, Inc. $21.65 02/26/2024 Food and Beverage Undisputed 01/23/2026 1078797393 CMS
LEO Pharma Inc. $29.33 07/02/2024 Food and Beverage Undisputed 01/23/2026 1152650961 CMS
Lilly USA, LLC $23.15 02/03/2024 Food and Beverage Undisputed 01/23/2026 1134976114 CMS
Lilly USA, LLC $18.95 02/07/2024 Food and Beverage Undisputed 01/23/2026 1134981790 CMS
Lilly USA, LLC $23.53 12/09/2024 Food and Beverage Undisputed 01/23/2026 1134976306 CMS
Organon Llc $17.44 10/15/2024 Food and Beverage Undisputed 01/23/2026 1136200987 CMS
PFIZER INC. $13.14 05/14/2024 Food and Beverage Undisputed 01/23/2026 1131916707 CMS
Regeneron Healthcare Solutions, Inc. $26.59 01/16/2024 Food and Beverage Undisputed 01/23/2026 1114169630 CMS
Regeneron Healthcare Solutions, Inc. $19.43 01/22/2024 Food and Beverage Undisputed 01/23/2026 1114169632 CMS
Regeneron Healthcare Solutions, Inc. $22.14 02/13/2024 Food and Beverage Undisputed 01/23/2026 1114169634 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.